Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2015, Article ID 363458, 4 pages
http://dx.doi.org/10.1155/2015/363458
Research Article

Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction

1Cardiology, Gazi Yasargil Education and Research Hospital, 21070 Diyarbakır, Turkey
2Cardiovascular Surgery, Gazi Yasargil Education and Research Hospital, 21070 Diyarbakır, Turkey

Received 2 June 2015; Revised 2 August 2015; Accepted 16 August 2015

Academic Editor: Terrence D. Ruddy

Copyright © 2015 Zülküf Karahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. L. Wang, R. M. McCredie, and D. E. L. Wilcken, “Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 8, pp. 1030–1034, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Stengerd, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing, “Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men,” Circulation, vol. 91, pp. 265–269, 1995. View at Google Scholar
  3. P. W. F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas, “Apolipoprotein E alleles and risk of coronary disease: a meta-analysis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 10, pp. 1250–1255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Kolovou and K. K. Anagnostopoulou, “Apolipoprotein E polymorphism, age and coronary heart disease,” Ageing Research Reviews, vol. 6, no. 2, pp. 94–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Anoop, A. Misra, K. Meena, and K. Luthra, “Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases,” Indian Journal of Medical Research, vol. 132, no. 10, pp. 363–378, 2010. View at Google Scholar · View at Scopus
  6. Y. A. Kesäniemi, C. Ehnholm, and T. A. Miettinen, “Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype,” Journal of Clinical Investigation, vol. 80, no. 2, pp. 578–581, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. R. W. Mahley and S. C. Rall Jr., “Apolipoprotein E: far more than a lipid transport protein,” Annual Review of Genomics and Human Genetics, vol. 1, no. 2000, pp. 507–537, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Davignon, R. E. Gregg, and C. F. Sing, “Apolipoprotein E polymorphism and atherosclerosis,” Arteriosclerosis, vol. 8, no. 1, pp. 1–21, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Siest, T. Pillot, A. Regis-Bailly et al., “Apolipoprotein E: an important gene and protein to follow in laboratory medicine,” Clinical Chemistry, vol. 41, no. 8, pp. 1068–1086, 1995. View at Google Scholar · View at Scopus
  10. C. Knouff, M. E. Hinsdale, H. Mezdour et al., “Apo E structure determines VLDL clearance and atherosclerosis risk in mice,” The Journal of Clinical Investigation, vol. 103, no. 11, pp. 1579–1586, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Ward, P. N. Mitrou, R. Bowman et al., “APOE genotype, lipids, and coronary heart disease risk: a prospective population study,” Archives of Internal Medicine, vol. 169, no. 15, pp. 1424–1429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. G. Gensini, “A more meaningful scoring system for determining the severity of coronary heart disease,” The American Journal of Cardiology, vol. 51, no. 3, p. 606, 1983. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Burman, A. Mente, R. A. Hegele, S. Islam, S. Yusuf, and S. S. Anand, “Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada,” Atherosclerosis, vol. 203, no. 1, pp. 192–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Mahley, K. E. Palaoğlu, Z. Atak et al., “Turkish heart study: lipids, lipoproteins, and apolipoproteins,” Journal of Lipid Research, vol. 36, no. 4, pp. 839–859, 1995. View at Google Scholar · View at Scopus
  15. P. P. Singh, M. Singh, D. P. Bhatnagar, T. Kaur, and S. P. Gaur, “Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease,” Indian Journal of Medical Sciences, vol. 62, no. 3, pp. 105–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. P. Singh, M. Singh, and S. S. Mastana, “APOE distribution in world populations with new data from India and the UK,” Annals of Human Biology, vol. 33, no. 3, pp. 279–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. W. F. Wilson, R. H. Myers, M. G. Larson, J. M. Ordovas, P. A. Wolf, and E. J. Schaefer, “Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham offspring study,” The Journal of the American Medical Association, vol. 272, no. 21, pp. 1666–1671, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Raber, Y. Huang, and J. W. Ashford, “ApoE genotype accounts for the vast majority of AD risk and AD pathology,” Neurobiology of Aging, vol. 25, no. 5, pp. 641–650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. D. Dergunov, “Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: mechanistic and clinical studies,” Biomedicine & Pharmacotherapy, vol. 65, pp. 597–603, 2011. View at Google Scholar
  20. T. A. Khan, T. Shah, D. Prieto et al., “Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals,” International Journal of Epidemiology, vol. 42, no. 2, pp. 475–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Haddy, D. De Bacquer, M. M. Chemaly et al., “The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe,” European Journal of Human Genetics, vol. 10, no. 12, pp. 841–850, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. D. Zende, M. P. Bankar, P. S. Kamble, and A. A. Momin, “Apolipoprotein E gene polymorphism and its effect on plasma lipids in arteriosclerosis,” Journal of Clinical and Diagnostic Research, vol. 7, no. 10, pp. 2149–2152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Attila, E. Acartürk, G. Eskandari et al., “Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey,” Clinica Chimica Acta, vol. 312, no. 1-2, pp. 191–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Lehtinen, T. Lehtimaki, T. Sisto, and J. P. Salenius, “Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women,” Atherosclerosis, vol. 7, pp. 83–91, 1995. View at Google Scholar
  25. A. M. Bennet, E. Di Angelantonio, Z. Ye et al., “Association of apolipoprotein e genotypes with lipid levels and coronary risk,” The Journal of the American Medical Association, vol. 298, no. 11, pp. 1300–1311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Y. Çiftdoğan, S. Coskun, C. Ulman, and H. Tıkız, “The association of apolipoprotein E polymorphism and lipid levels in children with a family history of premature coronary artery disease,” Journal of Clinical Lipidology, vol. 6, no. 1, pp. 81–87, 2012. View at Publisher · View at Google Scholar
  27. A. Mendes-Lana, G. G. Pena, S. N. Freitas et al., “Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto Study,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 1, pp. 49–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M.-D. Zhang, W. Gu, S.-B. Qiao, E.-J. Zhu, Q.-M. Zhao, and S.-Z. Lv, “Apolipoprotein e gene polymorphism and risk for coronary heart disease in the chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls,” PLoS ONE, vol. 9, no. 4, Article ID e95463, 2014. View at Publisher · View at Google Scholar · View at Scopus